IGF-1 treatment causes unique transcriptional response in neurons from individuals with idiopathic autism

BACKGROUND: Research evidence accumulated in the past years in both rodent and human models for autism spectrum disorders (ASD) have established insulin-like growth factor 1 (IGF-1) as one of the most promising ASD therapeutic interventions to date. ASD is phenotypically and etiologically heterogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Linker, Sara B., Mendes, Ana P. D., Marchetto, Maria C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320548/
https://www.ncbi.nlm.nih.gov/pubmed/32591005
http://dx.doi.org/10.1186/s13229-020-00359-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320548/
https://www.ncbi.nlm.nih.gov/pubmed/32591005
http://dx.doi.org/10.1186/s13229-020-00359-w

Ejemplares similares